लोड हो रहा है...
Intra-tumor delivery of zoledronate mitigates metastasis-induced osteolysis superior to systemic administration
Bisphosphonates (BPs) have recently been shown to have direct anti-tumor properties. Systemic treatment with BPs can have multiple adverse effects such as osteonecrosis of the jaw and BP induced bone fracturing and spine instability. While benefits of systemic BP treatments may outweigh risks, local...
में बचाया:
| में प्रकाशित: | J Bone Oncol |
|---|---|
| मुख्य लेखकों: | , , , , , , , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
Elsevier
2017
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5262502/ https://ncbi.nlm.nih.gov/pubmed/28138422 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jbo.2017.01.001 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|